A Comparison of Atrial Fibrillation Diagnosis Rates of the Conservative 24-hour Holter Test and Single-Lead Wearable Patches in Patients with Nonatherosclerotic Cerebral Infarction. ((AVANT-GARDE (Comparison of Atrial fibrillation Validation After Non-atheromatous STroke: electrocardiogram compARison for unDetermined Embolism : Prospective cohort study))

Not Applicable

• Conditions: Diseases of the circulatory system

• Registration Number: KCT0008110
• Lead Sponsor: The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 February 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

a multi-center prospective cohort study.
1. Acute and subacute cerebral infarction (7 days -6month after stroke onset)
2. Age over 18 years
3. without AF on Admission ECG
4. at least 18-hours or more recording on 24-hour Holter monitoring
5. at least 72-hours or more recording on single lead wearable patch
6. Patients who can use a single-lead wearable patch device and related applications

Exclusion Criteria

1. patients with known AF
2. Patient with valvular heart diseases related to AF (rheumatic mitral stenosis, a mechanical or bioprosthetic heart valve, or mitral valve repair, infective endocarditis)
3. Patients with underlying disease related to AF (binge drinking, recent cardiothoracic and noncardiac surgery (<2weeks), recent ST elevation myocardial infarction (MI) (<3month), pericarditis, myocarditis, hyperthyroidism, electrocution, pneumonia, and pulmonary embolism)
4. Patient with implanted pacemaker
5. LA enlargement =44mm
6. NT-proBNP (N-terminal pro-B-type natriuretic peptide) =1000 pg/mL
7. Patients with advanced systemic disease or coexisting neurological/psychiatric disease
8. Patients with contact dermatitis and other skin disorders
9. Patients who are unable to perform the study with other causes.

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Detection rate of Atrial Fibrillation

Secondary Outcome Measures

Name	Time	Method
Recurrence rates of stroke/TIA